Randall E. Kaye

Overview

Randall E. Kaye received an average of $1M in total compensation, including $412K in salary, at Longboard Pharmaceuticals between 2022 and 2023.

Source: SEC filings on April 12, 2024 and April 11, 2023.

Related executives

We found three more executives who work or worked at Longboard Pharmaceuticals.

Kevin Lind

Longboard Pharmaceuticals

Chief Executive Officer

Brandi Roberts

Longboard Pharmaceuticals

Chief Financial Officer

Philip Perera

Longboard Pharmaceuticals

Chief Medical Officer

News

You may also like